Abstract
Concurrent chemoradiation (CRT) is commonly used to treat advanced stage oropharyngeal cancer (OPC). CRT affects the immune system, but the specific effects on immune cell populations and function during and after treatment are poorly defined. This study was performed to assess the impact of CRT on T cell populations and their function during and after treatment in patients with advanced stage OPC.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology, Biology, Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
